HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-inflammatory effects of Reduning Injection on lipopolysaccharide-induced acute lung injury of rats.

AbstractOBJECTIVE:
To evaluate the protective effects of Reduning Injection (, RDN), a patent Chinese medicine, on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in rats and its underlying mechanisms of action.
METHODS:
Sixty male Sprague-Dawley rats were randomly divided into 6 groups, including normal control, model, dexamethasone (DEX, 5 mg/kg), RDN-H (720 mg/kg), RDN-M (360 mg/kg) and RDN-L (180 mg/kg) groups, with 10 rats in each group. Rats were challenged with intravenous injection of LPS 1 h after intraperitoneal treatment with RDN or DEX. At 6 h after LPS challenge, lung tissues and bronchoalveolar lavage fluid (BALF) were collected, and the number of inflammatory cells was determined. The right lungs were collected for histopathologic examination, measurement of gene and protein expressions, superoxide dismutase (SOD) and myeloperoxidase (MPO) activities.
RESULTS:
In vivo pretreatment of RDN (360, 720 mg/kg) significantly reduced the weight of wet to dry (W/D) ratio of lung, protein content in BALF, and led to remarkable attenuation of LPS-induced histopathological changes in the lungs. Meanwhile, RDN enormously decreased BALF total inflammatory cells, especially neutrophil and macrophage cell numbers. Moreover, RDN increased SOD activity, inhibited MPO activity, alleviated LPS-induced tumor neurosis factor-α (TNF-α) and inducible nitric oxide synthase (iNOS) expression in lung tissues. Furthermore, RDN (720 mg/kg) efficiently weakened nuclear factorkappa B (NF-κB) gene and protein expression.
CONCLUSION:
Anti-inflammatory effects of RDN was demonstrated to be preventing pulmonary neutrophil infiltration, lowering MPO activity, TNF-α and iNOS gene expression by inhibiting NF-κB activity in LPS-induced ALI.
AuthorsLu-ping Tang, Wei Xiao, Yi-fang Li, Hai-bo Li, Zhen-zhong Wang, Xin-sheng Yao, Hiroshi Kurihara, Rong-rong He
JournalChinese journal of integrative medicine (Chin J Integr Med) Vol. 20 Issue 8 Pg. 591-9 (Aug 2014) ISSN: 1993-0402 [Electronic] China
PMID24916807 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Drugs, Chinese Herbal
  • Lipopolysaccharides
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • reduning
  • Peroxidase
  • Nitric Oxide Synthase Type II
  • Superoxide Dismutase
Topics
  • Acute Lung Injury (drug therapy, enzymology, pathology)
  • Animals
  • Anti-Inflammatory Agents (administration & dosage, chemistry, pharmacology, therapeutic use)
  • Bronchoalveolar Lavage Fluid (cytology)
  • Cell Count
  • Chromatography, High Pressure Liquid
  • Drugs, Chinese Herbal (administration & dosage, chemistry, pharmacology, therapeutic use)
  • Gene Expression Regulation (drug effects)
  • Injections
  • Lipopolysaccharides
  • Lung (drug effects, enzymology, pathology)
  • Male
  • NF-kappa B (genetics, metabolism)
  • Nitric Oxide Synthase Type II (genetics, metabolism)
  • Peroxidase (metabolism)
  • Rats, Sprague-Dawley
  • Superoxide Dismutase (metabolism)
  • Tumor Necrosis Factor-alpha (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: